Breakfast Nutrition and Inpatient Glycemia

Sponsor
Duke University (Other)
Overall Status
Completed
CT.gov ID
NCT01805414
Collaborator
(none)
237
1
2
2
118.3

Study Details

Study Description

Brief Summary

A standard hospital meal often contains a high percentage of carbohydrates (CHO), which may not be ideal for patients with diabetes. This concern is particularly pertinent to the breakfast meal, which often contains mainly CHO. Clinical observations suggested that such diets elevate pre-lunch blood glucose (BG) values. The study team compared standard hospital "no concentrated sweets (NCS)" breakfast meals with more balanced meals. The study team hypothesized that a balanced breakfast would improve pre-lunch BG values.

This 8-week pilot study was conducted at Duke Hospital on two non-ICU cardiology wards. Ward A consisted mainly of patients with a primary diagnosis of coronary artery disease (CAD). Ward B consisted mainly of patients with a primary diagnosis of congestive heart failure (CHF). The intervention breakfast menu included 5 choices containing 40-45g of CHO. All patients on Ward A (with and without diabetes) were given the intervention breakfast for the first 4 weeks of the study, while those on Ward B received standard menus (60-75g CHO in NCS meals). After 4 weeks, the standard and intervention wards were switched. Data were collected only on patients with diabetes who were able to consume meals.

Condition or Disease Intervention/Treatment Phase
  • Other: Modified Carbohydrate Breakfast
  • Other: Control Breakfast
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
237 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
The Effect of a Targeted Breakfast Intervention on Inpatient Glycemic Control
Study Start Date :
Sep 1, 2012
Actual Primary Completion Date :
Nov 1, 2012
Actual Study Completion Date :
Nov 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Breakfast

40-45g carbs (300-350 kcal)

Other: Modified Carbohydrate Breakfast
Other Names:
  • Breakfast with 40-45g carbohydrates
  • Active Comparator: Control Breakfast

    These patients received the usual hospital breakfast which contained 40-45 g carbs.

    Other: Control Breakfast
    Other Names:
  • 40-45g carbs
  • Outcome Measures

    Primary Outcome Measures

    1. Relative change in Blood sugar [Pre-breakfast to pre-lunch, approximately 4 hours, daily for the study duration of 8 weeks.]

      The primary outcome will be the relative change between the pre-breakfast and pre-lunch blood glucose levels after the intervention breakfast. The hypothesis is that the intervention breakfast will lead to lower pre-lunch blood sugars. Blood glucoses will be measured before breakfast and lunch on eligible patients. This will occur every day for the duration of the study (8 weeks). The relative change between the pre-breakfast and pre-lunch blood glucose will be assessed by BG2 (pre-lunch) minus BG1 (pre-breakfast).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Adults with cardiovascular disease who were admitted to 2 pre-specified wards at Duke Medical Center during the study period

    • Diagnosis of diabetes (type 1 or 2) or newly identified hyperglycemia (blood glucose of >200 on 2 separate occasions)

    • Able to consume food by mouth

    Exclusion Criteria:
    • Intensive care patients

    • No intake by mouth (enteral, parenteral, NPO)

    • Taking in nutrition supplements (Ensure, etc)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Duke Medical Center Durham North Carolina United States 27710

    Sponsors and Collaborators

    • Duke University

    Investigators

    • Principal Investigator: Lillian F Lien, MD, Duke Medical Center
    • Study Director: Kathryn J Evans, NP, Duke Medical Center
    • Study Chair: Mark N Feinglos, MD, Duke Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Duke University
    ClinicalTrials.gov Identifier:
    NCT01805414
    Other Study ID Numbers:
    • Pro00031605
    First Posted:
    Mar 6, 2013
    Last Update Posted:
    Oct 14, 2015
    Last Verified:
    Feb 1, 2013

    Study Results

    No Results Posted as of Oct 14, 2015